KPA likely to launch new negotiation team

Published: 2012-01-26 06:56:00

Updated: 2012-01-26 06:56:00

The Korean Pharmaceutical Association (KPA) is likely to select new members in a special meeting tomorrow in an effort to re-negotiate with the government over controversial agreement to relinquish its monopoly on sales of basic medicines like aspirin and cold remedies in December.

“The incumb...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK